As demand for GLP-1 therapies explodes, India’s drug regulator moves to curb advertising amid rising concerns over misuse, access, and long-term impact
MoU to deploy Qure.ai’s chest X-ray solution across 20 government facilities aims to improve early detection in urban and rural populations
Former Interim CEO takes charge to drive strategic growth, strengthen clinical excellence, and advance patient-centric oncology innovation
They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market
Move aligns global biologics identity under the Biocon Biologics brand
Paid-up equity capital rises to Rs 973.19 crore following allotment to eligible employees
The study met its primary endpoint, showing a statistically significant and clinically meaningful improvement in progression-free survival
The company said the increase—up to 20%—takes effect immediately, or as current contracts allow
Industry, policymakers focus on AI-led regulatory harmonisation, FTAs, MSME support and market expansion as exports touch $28.29 billion till February FY26
Key FDA decisions and pivotal late-stage obesity and breast cancer data could reshape competitive positioning
Subscribe To Our Newsletter & Stay Updated
